Evaluation of uro-oncological surgical treatment during the Sars-CoV-2 pandemic in a Brazilian tertiary oncology institution, the new world epicenter

Imagem de Miniatura
Arquivos
art_SILVA_Evaluation_of_urooncological_surgical_treatment_during_the_SarsCoV2_2021.PDF (145.84 KB)
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2021
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
BRAZILIAN SOC UROL
Autores
Citação
INTERNATIONAL BRAZ J UROL, v.47, n.2, p.378-385, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: The rapid spread of coronavirus disease 2019 (COVID-19) has dramatic effects on individuals and health care systems. In our institute, a tertiary oncologic public hospital with high surgical volume, we prioritize maintaining cancer treatment as well as possible. The aim of this study is to evaluate if uro-oncological surgeries at pandemic are safe. Materials and Methods: We evaluated patients who underwent uro-oncological procedures. Epidemiological data, information on COVID-19 infection related to surgery and clinical characteristics of non-survival operative patients with COVID-19 infections were analyzed. Results: From 213 patients analyzed, Covid-19 symptoms were noticed in 8 patients at preoperative process or at hospital admission postponing operation; 161 patients were submitted to elective surgery and 44 to emergency surgery. From patients submitted to elective surgeries, we had 1 patient with laboratory confirmation of COVID-19 (0,6%), with mild symptoms and quick discharge. From the urgencies group, we had 6(13%) patients tested positive; 5 were taken to ICU with 4 deaths. Conclusion: Elective uro-oncological procedures at the COVID-19 epidemic period in a COVID-19-free Institute are safe, and patients who need urgent procedures, with a long period of hospitalization, need special care to avoid COVID-19 infection and its outcomes.
Palavras-chave
COVID-19 [Supplementary Concept], Urologic Neoplasms, Oncology Service, Hospital
URI
https://observatorio.fm.usp.br/handle/OPI/38992
Referências
  1. [Anonymous], 2020, LANCET ONCOL, V21, P603, DOI 10.1016/S1470-2045(20)30243-6
  2. [Anonymous], 2020, CLIN MAN SEV AC RESP
  3. [Anonymous], 2020, COVID 19 GUIDANCE TR, V17, P2020
  4. Campi R, 2020, EUR UROL, V78, P11, DOI 10.1016/j.eururo.2020.03.054
  5. Carneiro A, 2020, INT BRAZ J UROL, V46, P501, DOI [10.1590/S1677-5538.IBJU.2020.04.03, 10.1590/s1677-5538.ibju.2020.04.03]
  6. Ficarra V, 2020, MINERVA UROL NEFROL, V72, P369, DOI 10.23736/S0393-2249.20.03846-1
  7. Gillessen S, 2020, EUR UROL, V77, P667, DOI 10.1016/j.eururo.2020.03.026
  8. Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032
  9. Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
  10. Iscaife A, 2020, INT BRAZ J UROL, V46, P879, DOI [10.1590/S1677-5538.IBJU.2020.0316, 10.1590/s1677-5538.ibju.2020.0316]
  11. Lee J, 2020, BRIT J SURG, V107, pE250, DOI 10.1002/bjs.11697
  12. Lei S, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/JECLINM.2020.200331
  13. Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
  14. Mottet N, EAU EANM ESTRO ESUR
  15. Oderda M, 2020, EUR UROL, V78, P124, DOI 10.1016/j.eururo.2020.04.036
  16. Paramore L, 2020, BJU INT, V126, P248, DOI 10.1111/bju.15110
  17. Puliatti S, 2020, BJU INT, V125, pE7, DOI 10.1111/bju.15071
  18. Sampaio FJB, 2020, INT BRAZ J UROL, V46, P499, DOI [10.1590/S1677-5538.IBJU.2020.04.02, 10.1590/s1677-5538.ibju.2020.04.02]
  19. Stensland KD, 2020, EUR UROL, V77, P663, DOI 10.1016/j.eururo.2020.03.027
  20. Wallis CJD, 2020, EUR UROL, V78, P29, DOI 10.1016/j.eururo.2020.04.063
  21. Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/55
Artigos e Materiais de Revistas Científicas - ODS/03